Navigation Links
Crux Biomedical Named One of Top 50 Companies to Watch
Date:7/12/2010

MENLO PARK, Calif., July 12 /PRNewswire/ -- Crux Biomedical® was named one of "50 Companies to Watch" in an annual survey of medical device and diagnostic companies. The survey, conducted by Medical Device and Diagnostics Industry (MD+DI), was published in its June 2010 issue. The purpose of the survey was to identify firms that have either achieved success or have the potential to revolutionize medical practice with their respective products.

Crux Biomedical, founded in 2004 by Dr. Thomas Fogarty, has targeted the development of an advanced implantable vena cava filter (VCF) to prevent the occurrence of a potentially fatal  pulmonary embolism (PE).  Each year in the United States, approximately 600,000 patients develop a PE and an estimated 200,000 deaths occur. This is more than the combined deaths associated with breast cancer, highway fatalities and AIDS. The U.S. market for VCFs  is valued at $300MM and growing between 8-10% annually.

Although routinely used in the United States, currently cleared vena cava filters are associated with a variety of complications including filter tilt and retrieval difficulty. The  Crux VCF is designed to address limitations of currently available VCFs.  "The Crux VCF is designed to self-center in the vena cava and has the advantage of retrievability from either the femoral or jugular approach," stated Eric Johnson, V.P., R&D of Crux Biomedical.

Crux Biomedical is currently enrolling patients in its pivotal IDE study in the United States and several international locations. It expects to complete enrollment by the end of 2010. "We are very pleased with the initial physician response to the Crux Biomedical Vena Cava Filter and believe our device will better meet the needs of implanting physicians," stated Mel Schatz, CEO of Crux Biomedical.

The firm is located in Menlo Park, California and is privately funded by Alloy Ventures and Emergent Medical Partners.


'/>"/>
SOURCE Crux Biomedical
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Crux Biomedical Enrolls First Patient in Its Retrieve 2 U.S. Pivotal Trial
2. Drexel Biomedical Researchers Develop Device to Predict Diabetic Wound Healing
3. West Haven Firm Expands Biomedical Disposal Program with Community Economic Development Fund
4. Binder Biomedical, Inc. Announces the Release of the X-GRAFT(TM) Interspinous Device, as Part of Their QUANTUM(TM) Line of Spinal Allograft Devices, Manufactured at the University of Miami Tissue Bank
5. Tianyin to Present at 5th Annual Biomedical Forum by Sino American BioPharmaceutical Association
6. Biomedical Advanced Research and Development Authority (BARDA) Project for Radiation Exposure Research Awarded to SRI International
7. Volcano Corporation Completes Acquisition of Lumen Biomedicals Xtract(TM) Thrombus Aspiration Catheter
8. Nominations Open for the 2010 Dr. Paul Janssen Award for Biomedical Research
9. Subsidiary of Nova Biomedical Completes Acquisition of Assets of CCS Medicals Subsidiary, Sanvita, Inc.
10. OmegaGenesis Unveils Novel Nanotechnology Platform With Broad Biomedical Applications
11. NIH Funds New Wellstone Research Center for Muscular Dystrophy at Boston Biomedical Research Institute
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... 19, 2017  Sensus Healthcare, Inc. (NASDAQ: ... in the treatment of non-melanoma skin cancers and ... radiation therapy, today announced that it will report ... results on Thursday, February 2, 2017 after the market ... conference call with the investment community on Thursday, February ...
(Date:1/19/2017)... , January 19, 2017 Shire ... that the U.S. Food and Drug Administration (FDA) has ... New Drug Application (NDA) for SHP465, a long-acting, triple-bead, ... a potential once-daily treatment for Attention-Deficit/Hyperactivity Disorder (ADHD). The ... around June 20, 2017, the designated Prescription Drug User ...
(Date:1/19/2017)... January 19, 2017 Pfizer ... the Milner Therapeutics Consortium   Major ... Cambridge   The Milner ... PFE ) as a partner to the Milner Therapeutics ... enables the efficient transfer of materials between industry and ...
Breaking Medicine Technology:
(Date:1/20/2017)... Farmville, NC (PRWEB) , ... January 20, 2017 ... ... the vPEP ® Oscillating Positive Expiratory Pressure (OPEP) device, was featured in ... article by Doug Pursley, MEd, RRT-ACCS, FAARC, “Analysis of Three Oscillating Positive ...
(Date:1/20/2017)... ... January 20, 2017 , ... “The Land of More and ... the issue of world hunger, and shares the simple and achievable answer. “The Land ... and member of the Fairview Missionary Church in Angola, Indiana where he works with ...
(Date:1/19/2017)... ... January 19, 2017 , ... Next week after January 20th, the ... Congressional political games that circumvent health needs of over 30 million. Many interviews with ... anxieties and needs government public servants were suppose to prioritize. Interviews provided below. ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... innovators, engineers, and scientists from around the world, announces the launch of its ... quick and easy portal to research breakthroughs and trending news, vital information on ...
(Date:1/19/2017)... Park City, Utah (PRWEB) , ... January 19, ... ... Sundance Film Festival in a medical capacity this year. Drs. Alexander Paziotopoulos, Andrew ... Lounge to provide a condensed version of the clinic’s leading recovery program. ...
Breaking Medicine News(10 mins):